NCT07139405View on ClinicalTrials.gov

TRIGLYTZA® VERSUS METFORMIN IN OBESE ADULT TYPE 2 DIABETES (T2DM) PATIENTS OVER 24 WEEKS OF TREATMENT

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 28, 2026

Primary Completion Date

December 31, 2027

Study Completion Date

June 30, 2028

Conditions
Type 2 Diabetes (T2DM)
Interventions
DRUG

Metformin XR 1000mg

Arm 1: Metformin XR 1000mg Monotherapy (taken AM)

DRUG

Valsartan 80mg Tablet

Arm 2: Valsartan 80mg (taken PM)

DRUG

Valsartan 160mg tablet

Arm 3: Valsartan 160mg (taken PM)

DRUG

Celecoxib (Celebrex®) 100mg

Arm 2: Celecoxib 100mg (taken AM)

DRUG

Celecoxib (Celebrex®) 200mg

Arm 3: Celecoxib (taken AM)

DRUG

Metformin XR 500 mg

Arm 2: Metformin 500mg (taken AM)

All Listed Sponsors
lead

Myopharm Limited

OTHER